Supply Chain
Eligible providers will get payment of 2% of annual revenue from patient care plus an add-on payment.
The law is meant to ensure that healthcare doesn't buckle under the weight of any future pandemics or public health crises.
A "gray market" for bogus products has emerged, with profiteers hoping to benefit from hospitals' need for PPE.
The plans include details on reaching vulnerable populations including minorities, immunocompromised individuals and older adults.
The order could disrupt the global pharmaceutical supply chain, jeopardizing the ability to respond to COVID-19, PhRMA says.
A national strategy is needed to avoid redirecting supplies away from front-line caregivers, the survey concluded.
Providers, compounders, individual states and the FDA all have roles to play in stemming drug shortages during the pandemic.
The over 500,000 treatment courses will be made available for hospitals based on hospitalization and inpatient data.
COVID-19 is a weak-link problem, according to Gladwell, a keynote speaker on the opening day of AHIP's Institute and Expo Online 2020.
The COVID-19 pandemic has increased demand, and North America is projected to continue its global market dominance.